| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | TORC2 signaling | 3.14e-07 | 17 | 17 | 3 | GO:0038203 | |
| GeneOntologyCellularComponent | TORC2 complex | 4.49e-08 | 9 | 18 | 3 | GO:0031932 | |
| GeneOntologyCellularComponent | TOR complex | 1.17e-07 | 12 | 18 | 3 | GO:0038201 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | 1.11e-03 | 972 | 18 | 5 | GO:0140535 | |
| Domain | C2 | 7.72e-03 | 131 | 19 | 2 | PF00168 | |
| Domain | C2 | 8.42e-03 | 137 | 19 | 2 | SM00239 | |
| Domain | C2 | 9.02e-03 | 142 | 19 | 2 | PS50004 | |
| Domain | - | 9.76e-03 | 148 | 19 | 2 | 2.60.40.150 | |
| Domain | C2_dom | 1.19e-02 | 164 | 19 | 2 | IPR000008 | |
| Domain | BTB | 1.42e-02 | 180 | 19 | 2 | SM00225 | |
| Domain | BTB/POZ_dom | 1.49e-02 | 185 | 19 | 2 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 1.56e-02 | 189 | 19 | 2 | IPR011333 | |
| Pathway | WP_DRAVET_SYNDROME | 2.52e-06 | 28 | 14 | 3 | M45519 | |
| Pathway | WP_TARGET_OF_RAPAMYCIN_SIGNALING | 5.46e-06 | 36 | 14 | 3 | M39635 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 4.65e-05 | 73 | 14 | 3 | MM16641 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 9.55e-05 | 15 | 14 | 2 | M48306 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 2.09e-04 | 22 | 14 | 2 | M13897 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 2.29e-04 | 23 | 14 | 2 | MM14993 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER | 2.94e-04 | 26 | 14 | 2 | M27558 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 3.17e-04 | 27 | 14 | 2 | M27422 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 3.68e-04 | 367 | 14 | 4 | M48346 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 3.92e-04 | 30 | 14 | 2 | MM15170 | |
| Pathway | WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER | 4.47e-04 | 32 | 14 | 2 | M39445 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 4.51e-04 | 157 | 14 | 3 | MM15226 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 4.75e-04 | 33 | 14 | 2 | M11725 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 4.76e-04 | 160 | 14 | 3 | M27498 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 5.05e-04 | 34 | 14 | 2 | MM14992 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 5.35e-04 | 35 | 14 | 2 | M249 | |
| Pathway | REACTOME_REGULATION_OF_TP53_DEGRADATION | 5.66e-04 | 36 | 14 | 2 | MM15339 | |
| Pathway | WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING | 5.66e-04 | 36 | 14 | 2 | M39569 | |
| Pathway | REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION | 5.98e-04 | 37 | 14 | 2 | M27641 | |
| Pathway | PID_CXCR3_PATHWAY | 8.08e-04 | 43 | 14 | 2 | M222 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 9.25e-04 | 46 | 14 | 2 | MM14935 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 1.89e-03 | 66 | 14 | 2 | MM14990 | |
| Pathway | PID_MTOR_4PATHWAY | 2.07e-03 | 69 | 14 | 2 | M121 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 2.37e-03 | 74 | 14 | 2 | M17386 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 2.37e-03 | 74 | 14 | 2 | M39857 | |
| Pathway | WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING | 2.63e-03 | 78 | 14 | 2 | M39824 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 3.03e-03 | 304 | 14 | 3 | MM14960 | |
| Pathway | PID_CXCR4_PATHWAY | 4.29e-03 | 100 | 14 | 2 | M124 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 4.54e-03 | 103 | 14 | 2 | MM14752 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 4.72e-03 | 105 | 14 | 2 | M164 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 4.81e-03 | 106 | 14 | 2 | M27077 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 4.88e-03 | 360 | 14 | 3 | M27267 | |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 5.16e-03 | 110 | 14 | 2 | M27162 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 6.02e-03 | 119 | 14 | 2 | M48309 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 7.36e-03 | 132 | 14 | 2 | M39338 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 8.47e-03 | 142 | 14 | 2 | M27233 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.26e-02 | 175 | 14 | 2 | MM14941 | |
| Pathway | WP_CILIOPATHIES | 1.39e-02 | 184 | 14 | 2 | M39880 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 1.53e-02 | 1022 | 14 | 4 | MM15436 | |
| Pubmed | PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. | 7.73e-09 | 8 | 19 | 3 | 18030348 | |
| Pubmed | 1.65e-08 | 10 | 19 | 3 | 22609986 | ||
| Pubmed | Hsp70 associates with Rictor and is required for mTORC2 formation and activity. | 1.65e-08 | 10 | 19 | 3 | 18505677 | |
| Pubmed | Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney. | 1.65e-08 | 10 | 19 | 3 | 21413931 | |
| Pubmed | Identification of Protor as a novel Rictor-binding component of mTOR complex-2. | 1.57e-07 | 20 | 19 | 3 | 17461779 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 23030823 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 24469448 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 35926713 | ||
| Pubmed | The endolysosomal adaptor PLEKHM1 is a direct target for both mTOR and MAPK pathways. | 7.46e-07 | 33 | 19 | 3 | 33452816 | |
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 27016480 | ||
| Pubmed | Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction. | 8.48e-07 | 3 | 19 | 2 | 21170086 | |
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 34331380 | ||
| Pubmed | 1.68e-06 | 43 | 19 | 3 | 33472061 | ||
| Pubmed | mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. | 1.70e-06 | 4 | 19 | 2 | 16919458 | |
| Pubmed | Interaction between NBS1 and the mTOR/Rictor/SIN1 complex through specific domains. | 1.70e-06 | 4 | 19 | 2 | 23762398 | |
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 22550181 | ||
| Pubmed | Functional Impacts of the BRCA1-mTORC2 Interaction in Breast Cancer. | 1.70e-06 | 4 | 19 | 2 | 31771139 | |
| Pubmed | mTORC2 Assembly Is Regulated by USP9X-Mediated Deubiquitination of RICTOR. | 2.82e-06 | 5 | 19 | 2 | 33378666 | |
| Pubmed | ER stress inhibits mTORC2 and Akt signaling through GSK-3β-mediated phosphorylation of rictor. | 2.82e-06 | 5 | 19 | 2 | 21343617 | |
| Pubmed | 2.82e-06 | 5 | 19 | 2 | 18925875 | ||
| Pubmed | 2.82e-06 | 5 | 19 | 2 | 36927703 | ||
| Pubmed | CD146 Regulates Growth Factor-Induced mTORC2 Activity Independent of the PI3K and mTORC1 Pathways. | 2.82e-06 | 5 | 19 | 2 | 31665642 | |
| Pubmed | 2.82e-06 | 5 | 19 | 2 | 18566586 | ||
| Pubmed | 2.82e-06 | 5 | 19 | 2 | 19875983 | ||
| Pubmed | 4.24e-06 | 6 | 19 | 2 | 29567957 | ||
| Pubmed | Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling. | 4.24e-06 | 6 | 19 | 2 | 22307628 | |
| Pubmed | 4.24e-06 | 6 | 19 | 2 | 16962653 | ||
| Pubmed | 4.24e-06 | 6 | 19 | 2 | 22084251 | ||
| Pubmed | 4.24e-06 | 6 | 19 | 2 | 22500797 | ||
| Pubmed | 4.24e-06 | 6 | 19 | 2 | 21177249 | ||
| Pubmed | mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. | 5.93e-06 | 7 | 19 | 2 | 18570873 | |
| Pubmed | Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. | 5.93e-06 | 7 | 19 | 2 | 17277771 | |
| Pubmed | TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. | 5.93e-06 | 7 | 19 | 2 | 28489822 | |
| Pubmed | Protor-2 interacts with tristetraprolin to regulate mRNA stability during stress. | 5.93e-06 | 7 | 19 | 2 | 21964062 | |
| Pubmed | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. | 5.93e-06 | 7 | 19 | 2 | 15718470 | |
| Pubmed | 7.90e-06 | 8 | 19 | 2 | 17043309 | ||
| Pubmed | Rictor forms a complex with Cullin-1 to promote SGK1 ubiquitination and destruction. | 7.90e-06 | 8 | 19 | 2 | 20832730 | |
| Pubmed | Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. | 7.90e-06 | 8 | 19 | 2 | 18566587 | |
| Pubmed | 7.90e-06 | 8 | 19 | 2 | 15268862 | ||
| Pubmed | 1.02e-05 | 9 | 19 | 2 | 27340174 | ||
| Pubmed | 1.27e-05 | 10 | 19 | 2 | 11889558 | ||
| Pubmed | 1.86e-05 | 12 | 19 | 2 | 18851840 | ||
| Pubmed | 2.56e-05 | 14 | 19 | 2 | 21045808 | ||
| Pubmed | 4.30e-05 | 18 | 19 | 2 | 34171383 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.35e-04 | 497 | 19 | 4 | 36774506 | |
| Pubmed | Choroid plexuses carry nodal-like cilia that undergo axoneme regression from early adult stage. | 1.66e-04 | 35 | 19 | 2 | 37890489 | |
| Pubmed | 2.10e-04 | 215 | 19 | 3 | 35973513 | ||
| Pubmed | 3.75e-04 | 650 | 19 | 4 | 38777146 | ||
| Pubmed | 4.74e-04 | 284 | 19 | 3 | 29459677 | ||
| Interaction | PRR5L interactions | 1.24e-06 | 23 | 19 | 3 | int:PRR5L | |
| Interaction | PLEKHM1 interactions | 2.01e-05 | 57 | 19 | 3 | int:PLEKHM1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p13 | 2.58e-06 | 65 | 19 | 3 | chr11p13 | |
| Cytoband | 11p13 | 2.47e-04 | 56 | 19 | 2 | 11p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 2.42e-03 | 177 | 19 | 2 | chr15q21 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 6.42e-06 | 5 | 15 | 2 | 1333 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 9.61e-03 | 181 | 15 | 2 | 694 | |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_UP | 5.19e-06 | 163 | 19 | 4 | M2997 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP | 5.72e-06 | 167 | 19 | 4 | M2995 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-05 | 148 | 19 | 3 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-05 | 148 | 19 | 3 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.73e-05 | 155 | 19 | 3 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.73e-05 | 155 | 19 | 3 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 4.33e-05 | 163 | 19 | 3 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.41e-05 | 164 | 19 | 3 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-05 | 169 | 19 | 3 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 169 | 19 | 3 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.91e-05 | 170 | 19 | 3 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | Pericytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.00e-05 | 171 | 19 | 3 | bbc8d9fc83d37c9250345b1e76776610799de9ae | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 5.45e-05 | 176 | 19 | 3 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.54e-05 | 177 | 19 | 3 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.82e-05 | 180 | 19 | 3 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.92e-05 | 181 | 19 | 3 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.92e-05 | 181 | 19 | 3 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-05 | 184 | 19 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.21e-05 | 184 | 19 | 3 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-05 | 184 | 19 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-05 | 184 | 19 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.31e-05 | 185 | 19 | 3 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.52e-05 | 187 | 19 | 3 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.52e-05 | 187 | 19 | 3 | 6e5c38425b6b1d4774f8dcea7e146f1eab785c3e | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 7.27e-05 | 194 | 19 | 3 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 7.38e-05 | 195 | 19 | 3 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.61e-05 | 197 | 19 | 3 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.61e-05 | 197 | 19 | 3 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1_high|Mild / Condition, Lineage, Cell class and cell subclass | 7.72e-05 | 198 | 19 | 3 | 17aab4dc3b2cd6eb7dda77dd51bdc20490fcfe19 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.72e-05 | 198 | 19 | 3 | 2591e08e3fbee86ac40f11becd8147d6d39fded6 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.84e-05 | 199 | 19 | 3 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.96e-05 | 200 | 19 | 3 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.96e-05 | 200 | 19 | 3 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-04 | 86 | 19 | 2 | 1f44bb41835445aa60a2e3c31616c5847447a246 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 99 | 19 | 2 | bc89104d964a92e941734790459a0ce8457e1fff | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-04 | 103 | 19 | 2 | 3f4e4600c8a9af3534479ca19905c3d31c4c55bb | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-03 | 113 | 19 | 2 | feb3c6a7723263d58e5ce020a0097fedfcf78ca8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-03 | 115 | 19 | 2 | ac73aa06e617ed791c6ae9e38189bac74188c27b | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.19e-03 | 121 | 19 | 2 | 05c40fd39e6b6275f35aaad835f95a81fcbb0990 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.21e-03 | 122 | 19 | 2 | eae9d94f8510ac0f434942451d55c7260977b178 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-03 | 125 | 19 | 2 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-03 | 126 | 19 | 2 | 94bd9cfe982b41a3114885173eab55feb0fbbbae | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-03 | 126 | 19 | 2 | a4fc7ac4931d2fc8aa8196a62d809b698937aa9c | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.41e-03 | 132 | 19 | 2 | dc6edfa821a1cdc645668b0af5ba5ff80dee10bd | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.41e-03 | 132 | 19 | 2 | 60ced08bda5efc95a6f116cd0c6d1a779d99ed38 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.48e-03 | 135 | 19 | 2 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.50e-03 | 136 | 19 | 2 | 67d736096d6b6ddb4722809557f5e987063b8d23 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.50e-03 | 136 | 19 | 2 | 47663c5d81c766a333207a44fc5b58b07309ee76 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.50e-03 | 136 | 19 | 2 | 6d2e5b871f4cf8d64e6fe0be666fb3490797c635 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.50e-03 | 136 | 19 | 2 | 3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.50e-03 | 136 | 19 | 2 | fd4269d194c7c11c6ab4383393a01efab05cbace | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-5|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.52e-03 | 137 | 19 | 2 | a7c76201b8901b2ef7ebbb4dfe0cec0dc4534ef5 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.52e-03 | 137 | 19 | 2 | 5e97480f014f1d9267e8126f1d0e58acd22f36aa | |
| ToppCell | P07-Hematopoietic|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.54e-03 | 138 | 19 | 2 | fb8038393c2b88eb29bd23574c0c6178644900be | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 139 | 19 | 2 | 27dd36f5ef03fa97f0fdb19fbd259cb60e7962b3 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 139 | 19 | 2 | 2a54627947f8c6597c041f4785f8a4e52d0edfba | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.63e-03 | 142 | 19 | 2 | 5fd737c1fee9d97aee8955f1bf378ead3fce138d | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.63e-03 | 142 | 19 | 2 | 58bfff3284ae21150e4619511bd58622c16c5dde | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.63e-03 | 142 | 19 | 2 | 16f9945e835c3506b12d904778560d065a50f059 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.66e-03 | 143 | 19 | 2 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-03 | 144 | 19 | 2 | 1d05aa08603cba28c0c6511767e434c1f592a3aa | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-03 | 144 | 19 | 2 | d3f6f5da56794367ee3776bfd3a9dcf893efe0f0 | |
| ToppCell | P15-Hematopoietic|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.72e-03 | 146 | 19 | 2 | 2b3e6ff6069573ee213000aeab5de9a33afc1a99 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-03 | 147 | 19 | 2 | 9566398275cad79223db90ffe640830acf2db864 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 148 | 19 | 2 | ba277c898678dd36f8dc1d681301c71901b89055 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 148 | 19 | 2 | dfd3f2c4b884ea9e23831a242a89ac985b409640 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 148 | 19 | 2 | b4632029ebd14969bda59a1bd1454eadb8efe563 | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-03 | 150 | 19 | 2 | ccb782fbcb3122266354a112a9a850506664f44d | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.84e-03 | 151 | 19 | 2 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.84e-03 | 151 | 19 | 2 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.87e-03 | 152 | 19 | 2 | 854c841c1fc6300b7e9be9c98cbf9b0ce2678690 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_macrophage-Langerhans_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.92e-03 | 154 | 19 | 2 | 617ad0929d2ac0eeb7b8d9b0cba687176e684ed0 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-03 | 154 | 19 | 2 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-03 | 154 | 19 | 2 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-03 | 154 | 19 | 2 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-03 | 154 | 19 | 2 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-03 | 155 | 19 | 2 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.94e-03 | 155 | 19 | 2 | 5c7b68b59244525e3714806c205a57a2daebf423 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 156 | 19 | 2 | da4f35353a84d919e683554932f110e29568df33 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 156 | 19 | 2 | f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1 | |
| ToppCell | Myeloid-Myeloid-F|Myeloid / shred on cell class and cell subclass (v4) | 1.97e-03 | 156 | 19 | 2 | d6317843ae5c5749452889e768c187a9d9e8c7fe | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 1.97e-03 | 156 | 19 | 2 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 156 | 19 | 2 | f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-03 | 157 | 19 | 2 | 370f44047ef438b8f1124c2c2761c150c0d8c57f | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l8|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-03 | 157 | 19 | 2 | 5098675f64342c41c5ca3551b24962d10c83e64d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.99e-03 | 157 | 19 | 2 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.99e-03 | 157 | 19 | 2 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 158 | 19 | 2 | b3a810314e253b4fd0f578e759c36fdd21722934 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 158 | 19 | 2 | 0ed844ab625351a46b74edddf082279ed1bae5c6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.04e-03 | 159 | 19 | 2 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-03 | 159 | 19 | 2 | 5543f5aec6352a7c5923e55daf3ed40ff5cc0f0c | |
| ToppCell | FLU-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 2.04e-03 | 159 | 19 | 2 | 97c8e16a7ac10ebba96daee97f9fb1d4a404f23b | |
| ToppCell | FLU-Healthy-1|FLU / Virus stimulation, Condition and Cluster | 2.04e-03 | 159 | 19 | 2 | fe2a9f79b058e89214256e736f6e266830cdfa28 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.07e-03 | 160 | 19 | 2 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-03 | 160 | 19 | 2 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-03 | 160 | 19 | 2 | ec81814f3a475ba9bc049cb793bf93bc0b650d37 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-03 | 160 | 19 | 2 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.09e-03 | 161 | 19 | 2 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.09e-03 | 161 | 19 | 2 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.12e-03 | 162 | 19 | 2 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-03 | 163 | 19 | 2 | 130c84bca3f72ab7d1a4fee2990c3d01600318ed | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 2.14e-03 | 163 | 19 | 2 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.68e-04 | 447 | 19 | 4 | EFO_0000694, MONDO_0100096 | |
| Disease | atopic eczema, psoriasis | 2.44e-04 | 36 | 19 | 2 | EFO_0000274, EFO_0000676 | |
| Disease | response to beta blocker, heart rate | 6.14e-04 | 57 | 19 | 2 | EFO_0004326, EFO_0007766 | |
| Disease | age at onset, Myopia | 4.15e-03 | 150 | 19 | 2 | EFO_0004847, HP_0000545 | |
| Disease | epilepsy (implicated_via_orthology) | 4.88e-03 | 163 | 19 | 2 | DOID:1826 (implicated_via_orthology) | |
| Disease | cardioembolic stroke | 5.29e-03 | 170 | 19 | 2 | EFO_1001976 | |
| Disease | attempted suicide | 5.78e-03 | 178 | 19 | 2 | EFO_0004321 | |
| Disease | non-alcoholic fatty liver disease | 6.04e-03 | 182 | 19 | 2 | EFO_0003095 | |
| Disease | apolipoprotein B measurement | 8.37e-03 | 663 | 19 | 3 | EFO_0004615 | |
| Disease | eye morphology measurement | 8.55e-03 | 218 | 19 | 2 | EFO_0007858 | |
| Disease | amino acid measurement | 8.90e-03 | 678 | 19 | 3 | EFO_0005134 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.02e-02 | 713 | 19 | 3 | EFO_0005689 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TMDTHCQNEMSSGTG | 556 | Q6P2P2 | |
| MENQAHNTMGTSPCE | 1 | Q05D60 | |
| ATTATSNMAGQHGCS | 1091 | P51610 | |
| TTSTHTAMQGNMDTA | 721 | Q6ZVL6 | |
| VGVDATTMDTDCGSM | 1241 | Q6R327 | |
| TMMHSGLGEEASSEN | 306 | Q6MZQ0 | |
| SSCVVTQQMASMGSS | 1601 | Q92794 | |
| QGTMHTGSTLDSTMD | 3866 | Q4G0P3 | |
| HNSNMGSDSGTMGSD | 276 | Q9BYX4 | |
| MSSENPGMCGNADTT | 1756 | P56715 | |
| ECQSSEESMGSNSMR | 371 | Q2TAK8 | |
| NHSGCDSQMSVSEMS | 386 | Q8NB59 | |
| QSHVTSDDTGMCEMV | 16 | Q9BPZ7 | |
| NPDSGTMNHVESSMC | 291 | Q93073 | |
| TMNHVESSMCAGGVN | 296 | Q93073 | |
| HGMGSSLHEDMNCFS | 641 | Q8N961 | |
| NCSGMGAHLMTISTE | 111 | Q8WXI8 | |
| NTETVDSGMSNGMVC | 621 | Q8NB66 | |
| VNMSMGGTDGDTFSC | 466 | O95935 | |
| MEVAMVSAESSGCNS | 1 | P22459 |